Coronary Artery Aneurysm following Drug-Eluting Stent Implantation
| | |
Percutaneous coronary interventions (PCI) are uncommon causes of coronary artery aneurysms (CAA). The incidence of CAA after percutaneous transluminal coronary angioplasty (PTCA) ranges from 3.9–5%,1,2,5–7 and after directional coronary atherectomy from 2–10%.3,4 Though CAA after implantation of a stent is rare, it has been recently reported after implantation of a drug-eluting stent.8 We report a similar case of CAA following stenting with a drug-eluting stent.
Case Report. A 45-year-old woman with a known case of hypertension presented to our center with recent-onset NYHA class III angina despite being on optimal medical therapy. She was thus takenFigure 1
|  | | Coronary angiogram in RAO cranial view demonstrating mid-LAD obstruction. | for coronary angiography and possible revascularization. Coronary angiography showed total occlusion of the mid-left anterior descending (LAD) artery, with no significant lesions in the left circumflex or right coronary arteries and normal left ventricular function (Figure 1). The patient was taken the catheterization laboratory for PCI. The totally occluded LAD was easily crossed with a 0.014 inch BMW GuideFigure 2
|  | | Coronary angiogram in the same view after implantation of paclitaxel-eluting stent. | Wire (Guidant Corp., Indianapolis, Indiana) and dilated with a 2.5 x 15 mm Crosssail® balloon catheter (Guidant) at 8 atm. There was no dissection after balloon angioplasty. Following this, a 2.75 x 20 mm Taxus® drug-eluting stent (Boston Scientific Corp., Natick, Massachusetts) was deployed in the LAD at a pressure of 12 atm, resulting in TIMI 3 flow (Figure 2). The patient who was on regular follow-up was readmitted 6 months later with unstable angina. The electrocardiogram did not reveal any significant ST-T changes. She was sent for a coronary angiogram which revealed focal in-stent restenosis and a saccular aneurysm of 3.5 x 8 mm within the mid-portion of the stent (Figure 3).
Discussion. CAA following PTCA is usually a delayed finding. It is caused by the use of oversized balloons or high-pressure inflation of the balloon, resulting in intimal and medial tearing with Figure 3
|  | | Coronary angiogram in RAO view 6 months after stent implantation. There is significant in-stent restenosis along with a saccular aneurysm (arrow). Aneurysm segment is shown at higher magnification in the inset image. | continuous weakening and stretching of the artery,5–7 perforation of the media without penetration of blood through the adventitia, or deep resection by directional coronary atherectomy. Conversely, there have also been reports of rupture or rapid enlargement of an aneurysm in the early stages following PCI. These were likely perforations that progressed to pseudoaneurysms.9 Development of CAA after stenting in the present day is rare. Rab et al.10 reported CAA in 32% of patients who received glucocorticoid following bailout stenting. They suggested that steroid-mediated impairment of vascular healing might have led to weakening of the arterial wall and aneurysm formation, despite the presence of a reinforcing stent. Most reports have been associated with bailout stenting for coronary artery dissection following balloon angioplasty. Also, high-pressure balloon inflations commonly used to optimize the expansion of coronary stents may lead to small uncovered dissections and CAA formation.11 Incomplete coverage of edge dissection may lead to long-term coronary artery aneurysm formation. In the study by Slota et al.,12 CAA was higher in patients with dissection (8.9 versus 4.7%). In their study of 410 patients (PTCA = 203 patients and stent = 207 patients), the incidence of CAA was 5.4% at 6-month angiographic follow-up (3.9% in the stent group and 7% in the PTCA group). This study was performed before the routine use of high-pressure balloon inflation during stent implantation.
They could not find a predictive factor for the development of CAA. The restenosis rate and major cardiac events at 1-year follow-up were not different when patients with and without CAA were compared. The incidence of aneurysm formation is lower after stent implantation with currently used techniques. In the recently reported instances of CAA following implantation of sirolimus-eluting stents,8,13 the authors postulated that patient-specific sensitivity to the drug and incomplete stent apposition could have played a role. Since intravascular ultrasound assessment was not done in our patients, we cannot comment on whether incomplete stent apposition was responsible. Minor dissections, a universal phenomenon following balloon angioplasty, usually seal off and heal after stenting. However, drug-eluting stents having an antiproliferative action may be responsible not only for delay in intimal healing, but also for the tunica media. This delayed and inappropriate healing may be responsible for weakening of the arterial wall and delayed aneurysm formation. |
1. Bal ET, Plokker HWT, van der Berg EMJ, et al. Predictability and prognosis of PTCA induced coronary artery aneurysms. Cathet Cardiovasc Diagn 1991;22:85–88.
2. Vassanelli C, Turri M, Morando G, et al. Coronary arterial aneurysms after percutaneous transluminal coronary angioplasty — A not uncommon finding at elective follow up angiography. Int J Cardiol 1989;22:151–156.
3. Bell MR, Garrant KN, Bresnahan JF, et al. Relation of deep arterial resection and coronary artery aneurysms after DCA. J Am Coll Cardiol 1992;20:1474–1481.
4. Safian RD, Gelbfish JS, Erny RE, et al. Coronary atherectomy. Clinical, angiographic and histological finding regarding potential mechanisms. Circulation 1990;82:69–79.
5. Doucet S, Gagnon RM, Laramee P, Beaudet R. Late coronary aneurysm formation following coronary angioplasty. Can J Cardiol 1990;6:399–401.
6. Weston M, Bowerman R. Coronary artery aneurysm formation following PTCA. Cathet Cardiovasc Diagn 1987;13:181–184.
7. Hill J, Margolis J, Feldman R, et al. Coronary artery aneurysm formation after balloon angioplasty. Am J Cardiol 1983;52:261–264.
8. Stabile E, Escolar E, Weigold G, et al. Marked malapposition and aneurysm formation after sirolimus eluting coronary stent implantation. Circulation 2004;110:e47–e48.
9. Schobel WA, Voelker W, Haase KK, Karsch KR. Occurrence of a saccular pseudoaneurysm formation two weeks after perforation of the left anterior descending coronary artery during balloon angioplasty in acute myocardial infarction. Catheter Cardiovasc Interv 1999;47:341–346.
10. Rab ST, King III SB, Roubin GS, et al. Coronary aneurysm after stent placement: A suggestion of altered vessel wall healing in the presence of anti inflammatory agents. J Am Coll Cardiol 1991;18:1524–1528.
11. Berkalp B, Kervancioglu C, Oral D. Coronary artery aneurysm formation after balloon angioplasty and stent implantation. Int J Cardiol 1999;69:65–70.
12. Slota Pa, Fischmann DL, Savage MP, et al. Frequency and outcome of development of CAA after intracoronary stent placement and angioplasty. STRESS trial investigators. Am J Cardiol 1997; 79:1104–1106.
13. Degertekin M, Serruys PW, Tanabe K, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus eluting stent for de novo coronary lesions. An intravascular ultrasound analysis. Circulation 2003;108:2747–2750. |
| The Journal of Invasive Cardiology - ISSN: 1042-3931 - Volume 18 - Issue 1 (January 2006) - January 2006 - Pages: E66 - E67 | |
|
Create a Successful Vena Cava Filter Practice
Accredited CD
This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiologists, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.
|
| |
|
|
|
|
Achieving Optimal Outcomes in Carotid Stenting: Lessons Learned from Recent Clinical Trials
Complimentary Accredited ON DEMAND Webcast
Topics
1. EVA-3S & Space-Bumps in the road
2. CAPTURE 3500-Lesion morphology & Predictors for Stroke
3. CAPTURE II vs. EXACT 1500-Does open or Closed Cell Stent design really matter?
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists with an interest in the diagnosis and treatment of peripheral artery disease. |
|
Anticoagulation Techniques for Peripheral Vascular Interventions
Complimentary Accredited ON DEMAND Webcast
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.
|
|
|
|
|
|
March 2007 Supplement
|
On-Demand Webcast
|
Archived Webcast
|
|
|
|
|
|
About HMP Communications
HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP’s products and services at www.hmpcommunications.com. ©2008 HMP Communications |
© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd, Suite 100 | Malvern, PA 19355 | 800.237.7285
|
|
| | |